Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358757 · ClinicalTrials.gov registry record
Immune and Physical Recovery Following Cesarean Delivery
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 60
- Enrollment target
NCT04358757: Completed study, sponsored by Stanford University.
NCT04358757 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04358757 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whether this is an immune driven / associated process is to characterise what effects this surgery has on maternal immune function. "Normal" changes will be evaluated in maternal immune function and activity precipitated by surgery and delivery of the neonate. Immune response to surgery will be compared to historical immune data from patients undergoing non-obstetric surgery (orthopaedic patients).
Interventions
- PROCEDURE Elective cesarean delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-11-22 |
| Est. Completion | 2023-12-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04358757
The ClinicalTrials.gov registry entry for NCT04358757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Elective cesarean delivery is the first listed.
NCT04358757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04358757 about?
NCT04358757 is a clinical study titled "Immune and Physical Recovery Following Cesarean Delivery". Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whether this is an immune driven / associated process is to characterise what effects this surgery has on ...
What is the current status of trial NCT04358757?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2019-11-22. Estimated completion is 2023-12-23.
What interventions are being tested in trial NCT04358757?
The interventions under investigation include: Elective cesarean delivery (PROCEDURE).
Who is sponsoring clinical trial NCT04358757?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.